IGF2BP3 is an essential N6-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells.
Mater Today Bio
; 17: 100503, 2022 Dec 15.
Article
en En
| MEDLINE
| ID: mdl-36457846
ACSL3, acyl-CoA synthetase long chain family member 3; ALKBH5, alkB homolog 5; ELISA, enzyme-linked immunosorbent assay; FTH1, ferritin heavy chain 1; FTO, fat mass-and obesity-associated gene; Ferroptosis; GPX4, glutathione peroxidase 4; HNRNPA2B1, heterogeneous nuclear ribonucleoprotein A2/B1; IB, immunoblotting; IGF2BP3, insulin-like growth factor 2 mRNA binding protein 3; IHC, immunohistochemistry; LUAD, lung adenocarcinoma; Lung adenocarcinoma; MDA, malondialdehyde; METTL14, methyltransferase-like 14; METTL3, methyltransferase-like 3; PKM, pyruvate kinase M1/2; RBM15, RNA binding motif protein 15; ROS, reactive oxygen species; SLC3A2, solute carrier family 3 member 2; TMA, tissue microarray assay; Therapeutic target; VIRMA, vir-like m6A methyltransferase associated; WTAP, Wilms' tumor 1-associating protein; YTHDF2, YTH domain family 2; ZC3H13, zinc finger CCCH-type containing 13; m6A RNA methylation; m6A reader; m6A, N6-methyladenosine; qRT-PCR, quantitative reverse transcription PCR
Texto completo:
1
Bases de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Mater Today Bio
Año:
2022
Tipo del documento:
Article
País de afiliación:
China